From basic science to clinical research
Benedikt Linder, Daniel-Timon Spanka
Alcedis GmbH, Gießen
​
20. Jan 2025 15:00h
Location: Seminarroom, IBCII, Bldg. 75, Campus Niederrad, GU Frankfurt
Hybrid Lecture
​
.jpg)
Application of LiP-MS in drug discovery:
From global target ID and selectivity profiling to binding site mapping
Yuehan Feng
Biognosys AG, Schlieren, Switzerland
​
27. Jun 2024 15:00h
Location: Virtual Lecture
​
Innovative approaches to proximity-inducing compound design: AI meets physics-based modeling
Alzbeta Tuerkova
Celeris Therapeutics, R&D Excellence Center, Graz, Austria
​
29. Nov 2023 16:00h
Location: Virtual Lecture
​
Molecular origami: The TRiCky business of folding proteins in the cell
Judith Frydman
James H Clark Center
Stanford University, USA
Jochen Hückmann-Stiftungsgastprofessur für Forschungsexzellenz
​
02. Jun 2023 11:00h
Location: Uni Campus Riedberg,
Otto-Stern-Zentrum, Hall H2
​
Induced proximity medicines: Targeted protein degradation and beyond
Ryan Potts
Amgen, US
​
26. Sep 2022 16:15h
Location: Lecture Hall H20-5, Bldg. 20, Campus Niederrad
Hybrid Lecture
​
Download Announcement
Download Agenda
Design and synthesis of inhibitors targeting CNS kinases
Prof. Dr. Pierre Koch
Pharmazeutisches Institut, Lehrstuhl Pharm./Med. Chem. II, Universität Regensburg
​
22. Nov 2021 17:00h
Location: Auditorium H2, Otto-Stern-Zentrum, Campus Riedberg
Virtual Lecture
The coming of age of de novo protein design
Prof. Dr. David Baker
Washington University, Seattle
22. Jun 2021 17:00h
Location: Virtual Meeting
Virtual Lecture
Large-scale chemoproteomic profiling surveys the degradable proteome for accelerated degrader development
Katherine A. Donovan
Dana-Farber Cancer Institute & Harvard Medical School,
Boston, US
18. May 2021 16:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
​
Reimagining druggability using chemoproteomic platforms
Daniel K. Nomura
University of California,
Berkeley, US
16. Nov 2020 17:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
Manipulating developmental pathways using proximity-inducing antibody modalities
Stephane Angers
Leslie Dan Faculty of Pharmacy,
University of Toronto,CA
01. Sep 2020 16:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
Induced proximity-based drug discovery – Development of PROTACs and beyond
Christian Steinebach
Pharmaceutical Institute, University of Bonn
9. Dec 2024 16:00h
Location: Virtual Lecture
PROTACs and targeted protein degradation: A new therapeutic modality
Craig Crews
Lewis Cullman Professor of Molecular,
Cellular and Development Biology
and Professor of Chemistry and
Pharmacology, Yale (USA)
​
13. May 2024 16:15h
Location: TU Darmstadt, Foyer of
Wilhelm-Köhler Saal (Room 284)
Hall S1/03, Hochschulstr. 1
​
Emerging approaches for drug delivery
Scientific symposium organized as part of the Merz Guest Professorhsip - renowned experts in the field of drug delivery present their latest results
​
09. Nov 2023 full day
Location: Campus Friedberg, Biocenter, Lecture Hall B1, Max-von-Laue-Str. 9, 60439 Frankfurt
​
Targeting protein modification and degradation
Edward W. Tate
GSK Chair in Chemical Biology, Imperial College
& The Francis Crick Institute
UK
​
06. Mar 2023 18:00h
Location: GU Frankfurt - Uniklinik
Haus 22, Hörsaal 2
Hybrid Lecture
​
Analyzing and targeting oncogenic transcription factors by directed protein degradation
Prof. Dr. Elmar Wolf
Julius-Maximilians-Universität Würzburg, Biozentrum, Würzburg, Germany
​
23. May 2022 15:00h
Location: Lecture Hall H27B, Bldg. 27, Campus Niederrad
Hybrid Lecture
Identifying fragments binding to the entire genome and proteome of SARS-CoV-2
Prof. Dr. Harald Schwalbe
Institute for Organic Chemistry and Chemical Biology, Johann Wolfgang Goethe-University Frankfurt
​
27. Oct 2021 16:00h
Location: UKF, auditorium 23-3
Hybrid Lecture
Mapping the degradable kinome provides a resource for drug discovery
Fleur M. Ferguson
University of California San Diego,
La Jolla, US
01. Jun 2021 17:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
Regulation of histone methylation with methyl-lysine reader targeted degraders
Lindsey Ingerman James
University of North Carolina,
Chapel Hill, US
31. Mar 2021 16:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
Molecular mechanisms of small molecule mediated ubiquitin ligase targeting
Eric Fischer
Dana-Farber Cancer Institute & Harvard Medical School,
Boston,US
27. Oct 2020 16:30h
Location: Virtual Lecture via Zoom
Virtual Lecture
Multispecific drugs, induced proximity, and the future of biopharmaceutical innovation
Ray Deshaies
Senior Vice President,
Global Research,
AMGEN, USA
25. Aug 2020 17:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
1st Symposium
Advances in Therapeutic Approaches
EnABLE, PROXIDRUGS and the TheraNova Performance Centre are jointly organizing a symposium, where current research results on innovative therapies and pharmaceuticals are presented.
5.-6. Dec 2024
​Campus Westend
Goethe University Franfkurt
​
Chasing molecular glues and coping with resistance to degraders
Cristina Mayor-Ruiz
Institute for Research in Biomedicine (IRB), Barcelona
​
29. Jan 2024 16:00h
Location: Virtual Lecture
​
Spatiotemporal identification of binding sites with deep learning
Petr Popov
Tetra-d, München
​
18. Oct 2023 16:00h
Location: Virtual Lecture
​
Disrupting oncogenic gene control via targeted protein degradation
Georg Winter
CeMM – The Research Center for Molecular Medicine
of the Austrian Academy of Sciences
​
28. Nov 2022 17:00h
Location: TU Darmstadt, Campus Lichtwiese, Alarich-Weiss-Straße 6, L203/06
Hybrid Lecture
​
Transcription-coupled DNA repair:
Lessons learned on the ubiquitylation of complex substrates
Goran Kokic
Max Planck Institute for Biophysical Chemistry, Göttingen, Germany
​
18. Jan 2022 16:00h
Location: Virtual Lecture
Multidisciplinary approaches in the development of targeted protein degraders
Radoslaw Nowak
Dana-Farber Cancer Institute,
Harvard Medical School
14. Sep 2021 17:00h
Location: Virtual Meeting
Virtual Lecture
Rapid response technologies for protein manufacturing and drug discovery
Prof. Dr. Bradley Pentelute
Massachusetts Institute of Technology Boston
25. May 2021 15:00h
Location: to be announced
Virtual Lecture
Lessons from thalidomide analogues as prototype molecular glue degraders
Philip Chamberlain
Neomorph, Inc.
16. Feb 2021 17:00h
Location: Virtual Lecture via Zoom
Virtual Lecture
Probing gene control via targeted protein degradation
Georg Winter
Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM), Vienna, AT
29. Sep 2020 16:00h
Location: Virtual Lecture via Zoom; Meeting-ID: 962 0881 2086 Kenncode: 612251
Virtual Lecture